Participants 56 100 3
microdose flare-up cycles in poor responders
Participants 206 294 3
microdose gonadotropin-releasing hormone analog (GnRH-a) flare cycles in poor responders
Participants 391 400 7
119 women
Participants 587 678 3
119 patients were randomized in three groups to receive daily fixed doses of 300 IU of rFSH
